Analgesic nephropathy: removal of phenacetin from proprietary analgesics.
Journal: 1972/December - British Medical Journal
ISSN: 0007-1447
PUBMED: 5078444
Abstract:
Since phenacetin was withdrawn from Askit Powders and Beecham's Powders in 1966 these preparations have declined in importance as a cause of analgesic nephropathy in Western Scotland. In most patients with analgesic nephropathy who persist in abuse of compound analgesics renal function continues to decline. The deterioration, however, is less rapid among those taking aspirin and caffeine mixtures than in those taking preparations which also contain phenacetin.
Relations:
Content
Citations
(8)
References
(11)
Diseases
(2)
Drugs
(6)
Chemicals
(2)
Organisms
(1)
Similar articles
Articles by the same authors
Discussion board
Br Med J 4(5833): 131-132

Analgesic Nephropathy: Removal of Phenacetin from Proprietary Analgesics

Abstract

Since phenacetin was withdrawn from Askit Powders and Beecham's Powders in 1966 these preparations have declined in importance as a cause of analgesic nephropathy in Western Scotland. In most patients with analgesic nephropathy who persist in abuse of compound analgesics renal function continues to decline. The deterioration, however, is less rapid among those taking aspirin and caffeine mixtures than in those taking preparations which also contain phenacetin.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (358K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abel JA. Analgesic nephropathy--A review of the literature, 1967-1970. Clin Pharmacol Ther. 1971 Jul-Aug;12(4):583–598. [PubMed] [Google Scholar]
  • Bell D, Kerr DN, Swinney J, Yeates WK. Analgesic nephropathy. Clinical course after withdrawal of phenacetin. Br Med J. 1969 Aug 16;3(5667):378–382.[PMC free article] [PubMed] [Google Scholar]
  • Bengtsson V. Phenacetin. Lancet. 1969 Feb 1;1(7588):264–265. [PubMed] [Google Scholar]
  • Kjaerulff J, Harvald B. Incidensen af papillitis necroticans. Nord Med. 1968 Nov 21;80(47):1588–1590. [PubMed] [Google Scholar]
  • Koutsaimanis KG, de Wardener HE. Phenacetin nephropathy, with particular reference to the effect of surgery. Br Med J. 1970 Oct 17;4(5728):131–134.[PMC free article] [PubMed] [Google Scholar]
  • Murray RM, Lawson DH, Linton AL. Analgesic nephropathy: clinical syndrome and prognosis. Br Med J. 1971 Feb 27;1(5747):479–482.[PMC free article] [PubMed] [Google Scholar]
  • Murray RM, Greene JG, Adams JH. Analgesics abuse and dementia. Lancet. 1971 Jul 31;2(7718):242–245. [PubMed] [Google Scholar]
  • Murray RM, Smith R. Coexistent analgesic nephropathy and bromism. Lancet. 1972 Jan 8;1(7741):73–74. [PubMed] [Google Scholar]
  • Nanra RS, Kincaid-Smith P. Papillary necrosis in rats caused by aspirin and aspirin-containing mixtures. Br Med J. 1970 Sep 5;3(5722):559–561.[PMC free article] [PubMed] [Google Scholar]
  • Nordenfelt O. Deaths from renal failure in abusers of phenacetin-containing drugs. Acta Med Scand. 1972 Jan-Feb;191(1-2):11–16. [PubMed] [Google Scholar]
  • Shelley JH. Phenacetin, through the looking glass. Clin Pharmacol Ther. 1967 May-Jun;8(3):427–471. [PubMed] [Google Scholar]
Abstract
Since phenacetin was withdrawn from Askit Powders and Beecham's Powders in 1966 these preparations have declined in importance as a cause of analgesic nephropathy in Western Scotland. In most patients with analgesic nephropathy who persist in abuse of compound analgesics renal function continues to decline. The deterioration, however, is less rapid among those taking aspirin and caffeine mixtures than in those taking preparations which also contain phenacetin.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.